SCHEMBL5865844

SCHEMBL5865844

OC(c1ccco1)C(F)(F)C(O)c1ccco1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.47
POLB P06746 2/20 0.47
PKM P14618 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN7 P35236 1/20 0.47
BLM P54132 1/20 0.47
ESR2 Q92731 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 4/20 0.42
AGTR1 P30556 1/20 0.42
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALOX5 P09917 1/20 0.35
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
OPRM1 P35372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2421055 0.86 KMT2A (0.47) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL24361188 0.78 KMT2A (0.53) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL7118634 0.77 KMT2A (0.47) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL1925252 0.77 KMT2A (0.47) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL11151822 0.75 KMT2A (0.58) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL15272327 0.75 KMT2A (0.58) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL15272598 0.75 KMT2A (0.58) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL30324119 0.74 KMT2A (0.44) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL9963469 0.73 KMT2A (0.38) KMT2APOLBPKMPTPN1PTPN7
SCHEMBL12572721 0.73 KMT2A (0.38) KMT2APOLBPKMPTPN1PTPN7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087789-B2 Methods for nucleophilic fluoromethylation UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2006-08-08 US claimed
US-20040230079-A1 Methods for nucleophilic fluoromethylation SOUTHERN CALIFORNIA, UNIVERSITY OF 2004-11-18 US claimed
WO-2004063129-A2 METHODS FOR NUCLEOPHILIC FLUOROMETHYLATION UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2004-07-29 WO claimed
US-7087789-B2 Methods for nucleophilic fluoromethylation UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2006-08-08 US disclosed
US-20040230079-A1 Methods for nucleophilic fluoromethylation SOUTHERN CALIFORNIA, UNIVERSITY OF 2004-11-18 US disclosed
WO-2004063129-A2 METHODS FOR NUCLEOPHILIC FLUOROMETHYLATION UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2004-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040230079-A1 Methods for nucleophilic fluoromethylation PHF2, HAO2, GSTM2 KMT2A 1266/4885POLB 1463/4885PKM 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.